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Brief Clinical Reportsfor portions of the repair (ie, annuloplasties and tightening of
neochordae).
Complete absence of chordal structures associated with
leaflet prolapse, such as seen with a cleft in the anterior mi-
tral leaflet, creates a difficult problem for short- and long-
term outcomes in pediatric patients. Routine maneuvers
such as commissuroplasties and annuloplasties are not al-
ways effective. More complex techniques including creating
neochordae3 or creating a double-orifice mitral valve (ie, the
Alfieri repair6) can often provide effective short-term results.
Alfieri’s initial description6 of edge-to-edge leaflet approxi-
mation for adults with severe regurgitation has proven excel-
lent results and should be considered in children. However,
the creation of neochordae3,4 for significant prolapse pro-
vides a more natural effect and less potential for mitral ste-
nosis; if necessary, as the child grows, the neochordae can
be replaced without valve replacement.
Using preoperative and intraoperative 3- and 2-dimen-
sional echocardiography, one is able to optimally plan an
approach and the repair of complicated mitral valve abnor-
malities. Furthermore, as an alternative to complete cardio-
plegic arrest, spontaneously induced hypothermic
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The Journal of Thoracic and Camuch of the repair under more physiologic conditions with-
out significantly compromising myocardial function.
I would like to thank Dr Pedro del Nido for his continuing contri-
butions to the field of congenital valve disease and repair. Dr del
Nido at BostonChildren’s Hospital developedmany of the concepts
used herein, passing them to me during my time in Boston. I would
also like to thank Heather Claremont for help with the illustrations.
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1995;9:621-6; discussion 626-7.Iatrogenic phrenic nerve injury during thymectomy: The extent of
the problemMichele Salati, MD,a Giuseppe Cardillo, MD, FETCS,b Luigi Carbone, MD,b Federico Rea, MD,c
Giuseppe Marulli, MD,c Alessandro Brunelli, MD,a Luca Voltolini, MD,d Giuseppe Gotti, MD,d and
Gaetano Rocco, MD, FRCSEd,e Ancona, Rome, Padua, Siena, and Naples, ItalyIf a thymic neoplasm infiltrates both the phrenic nerves, it is
mandatory to spare one of them to reduce respiratory function
impairment.1 Toour knowledge, there is no information in theliterature regarding the incidence of unilateral phrenic nerve
resection for radically treated thymic neoplasms (Figure 1).
CLINICAL SUMMARY
In January 2007 we created a multi-institutional disease-
specific database. We retrospectively gathered data in an
electronic format from 5 Italian thoracic surgery units,
each of them performing at least 8 thymectomies per year,
irrespective of the surgical approach.
We enrolled 183 patients (93 female and 90 male patients;
median age, 56.6 years) from January 2000 to December
2006 who were operated on for thymoma or thymic carci-
noma. Patients with a preoperative diagnosis of generalized
myasthenia or other neuromuscular syndromes were ex-
cluded.
Two of the following criteria should be verified to define
the phrenic nerve as injured after the operation: (1) descrip-
tion of the phrenic nerve resection within the operatingrdiovascular Surgery c Volume 139, Number 4 e77
FIGURE 1. Thymic neoplasm infiltrating the phrenic nerve.
TABLE 1. Patients’ classification and incidence of phrenic nerve
injury by stage of thymoma
Categories
Patients,
no. (%)*
Resected phrenic
nerve, no. (%)y
Histology
WHO
Thymoma A 22 (12%) 2 (9%)
Thymoma AB 64 (35%) 3 (5%)
Thymoma B1 26 (14%) 2 (8%)
Thymoma B2 33 (18%) 2 (6%)
Thymoma B3 31 (17%) 3 (10%)
Thymoma C 7 (4%) 1 (14%)
Masaoka
Stage
Stage I 53 (29%) 1 (2%)
Stage II 99 (54%) 10 (10%)
Stage III 24 (13%) 2 (8%)
Stage IV 7 (4%) 0 (0)
Surgical
approach
Sternotomy 168 (92%)
Sternotomy
þ thoracotomy
1 (0.5%)
Thoracotomy 9 (5%)
Cervicotomy 1 (0.5%)
Robot 4 (2%)
WHO, World Health Organization. *Percentage calculated based on the total of pa-
tients in the study as denominator. yPercentage calculated based on the number of
patients per stage as denominator.
Brief Clinical Reportsreport, (2) description of a phrenic nerve segment detected
during the pathologic examination, and (3) postoperative
chest radiographic finding of an elevated hemidiaphragm
(in patients without this finding in the preoperative chest
radiograph).
Table 1 summarizes histopathologic diagnosis, stage, sur-
gical approach of the patients in analysis, and incidence of
phrenic nerve injuries in each stage.
Of the 183 patients, 13 met the criteria to be considered
affected by a surgical injury of the phrenic nerve. This means
that in our experience to achieve a radical resection of the
thymic tumor in our patients, we had to sacrifice the phrenic
nerve in about 7% of them. The postoperative cardiopulmo-
nary morbidity rate was 7% without mortality.DISCUSSION
Surgical intervention has always been considered a funda-
mental tool to treat tumors of the thymus gland.2,3 Used
alone or integrated in a multimodality approach, the surgical
treatment should lead to a radical resection of the tumor also
in those cases in which it invades the lung, pleura, dia-
phragm, vascular structures (superior vena cava and brachio-
cephalic vein), pericardium, or phrenic nerve.4,5 This study
was designed primarily to assess the incidence of phrenic
nerve resection during thymectomy. Further analyses aree78 The Journal of Thoracic and Cardiovascular Surgneeded to ascertain the effect of this lesion on residual respi-
ratory function and quality of life. These will be crucial fac-
tors in revising informed consent policies and comparing
clinical outcomes. In this setting the next task will be to as-
certain phrenic nerve injury–related pulmonary functional
loss and collect figures from distributed quality-of-life ques-
tionnaires with the aim to provide useful data for patient
counseling and medicolegal implications.References
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